Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor
- 5 July 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (13) , 3419-3424
- https://doi.org/10.1016/j.bmcl.2004.04.078
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Recent developments in modulating chemokine networksExpert Opinion on Therapeutic Patents, 1999
- Opportunities for novel therapeutic agents acting at chemokine receptorsDrug Discovery Today, 1999
- Chemokine Receptors and Chemokines in HIV InfectionJournal of Clinical Immunology, 1998
- Chemokine Receptors As HIV Co-Receptors: Targets for Therapeutic Intervention in AIDSPublished by Elsevier ,1998
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesPublished by Elsevier ,1996
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5Nature, 1996
- Identification of a major co-receptor for primary isolates of HIV-1Nature, 1996
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion CofactorsCell, 1996
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995